240 related articles for article (PubMed ID: 35014010)
1. The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.
Joyo Y; Kawaguchi Y; Yonezu H; Senda H; Yasuma S; Shiraga H; Nozaki M; Aoyama M; Asai K; Murakami H; Waguri-Nagaya Y
Immunol Res; 2022 Apr; 70(2):208-215. PubMed ID: 35014010
[TBL] [Abstract][Full Text] [Related]
2. The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
Kawaguchi Y; Waguri-Nagaya Y; Tatematsu N; Oguri Y; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
Clin Exp Rheumatol; 2018; 36(4):559-567. PubMed ID: 29352846
[TBL] [Abstract][Full Text] [Related]
3. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
[TBL] [Abstract][Full Text] [Related]
4. The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes.
Ikuta K; Waguri-Nagaya Y; Kikuchi K; Yamagami T; Nozaki M; Aoyama M; Asai K; Otsuka T
Arthritis Res Ther; 2012 Apr; 14(2):R87. PubMed ID: 22534375
[TBL] [Abstract][Full Text] [Related]
5. Mithramycin has inhibitory effects on gliostatin and matrix metalloproteinase expression induced by gliostatin in rheumatoid fibroblast-like synoviocytes.
Tatematsu N; Waguri-Nagaya Y; Kawaguchi Y; Oguri Y; Ikuta K; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
Mod Rheumatol; 2018 May; 28(3):495-505. PubMed ID: 28741989
[TBL] [Abstract][Full Text] [Related]
6. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
[TBL] [Abstract][Full Text] [Related]
7. Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes.
Tanikawa T; Waguri-Nagaya Y; Kusabe T; Aoyama M; Asai K; Otsuka T
Rheumatol Int; 2007 Apr; 27(6):553-9. PubMed ID: 17103175
[TBL] [Abstract][Full Text] [Related]
8. FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes.
Yamagami T; Waguri-Nagaya Y; Ikuta K; Aoyama M; Asai K; Otsuka T
Rheumatol Int; 2011 Jul; 31(7):903-9. PubMed ID: 20238216
[TBL] [Abstract][Full Text] [Related]
9. Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes.
Toyoda Y; Tabata S; Kishi J; Kuramoto T; Mitsuhashi A; Saijo A; Kawano H; Goto H; Aono Y; Hanibuchi M; Horikawa H; Nakajima T; Furukawa T; Sone S; Akiyama S; Nishioka Y
Arthritis Rheumatol; 2014 Mar; 66(3):560-8. PubMed ID: 24574215
[TBL] [Abstract][Full Text] [Related]
10. Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.
Muro H; Waguri-Nagaya Y; Mukofujiwara Y; Iwahashi T; Otsuka T; Matsui N; Moriyama A; Asai K; Kato T
Rheumatology (Oxford); 1999 Dec; 38(12):1195-202. PubMed ID: 10587545
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytes.
Karonitsch T; Beckmann D; Dalwigk K; Niederreiter B; Studenic P; Byrne RA; Holinka J; Sevelda F; Korb-Pap A; Steiner G; Smolen JS; Pap T; Kiener HP
Rheumatology (Oxford); 2018 Mar; 57(3):572-577. PubMed ID: 29228301
[TBL] [Abstract][Full Text] [Related]
12. IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes : JAKinibs suppress the interferon response in RA-FLSs.
Bonelli M; Dalwigk K; Platzer A; Olmos Calvo I; Hayer S; Niederreiter B; Holinka J; Sevelda F; Pap T; Steiner G; Superti-Furga G; Smolen JS; Kiener HP; Karonitsch T
Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31285419
[TBL] [Abstract][Full Text] [Related]
13. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.
Kusabe T; Waguri-Nagaya Y; Tanikawa T; Aoyama M; Fukuoka M; Kobayashi M; Otsuka T; Asai K
Rheumatol Int; 2005 Oct; 25(8):625-30. PubMed ID: 15990992
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F
Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
Aota K; Yamanoi T; Kani K; Ono S; Momota Y; Azuma M
Inflammation; 2021 Feb; 44(1):206-216. PubMed ID: 32772240
[TBL] [Abstract][Full Text] [Related]
17. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon.
Rosengren S; Corr M; Firestein GS; Boyle DL
Ann Rheum Dis; 2012 Mar; 71(3):440-7. PubMed ID: 22121136
[TBL] [Abstract][Full Text] [Related]
18. Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function.
O'Brien A; Hanlon MM; Marzaioli V; Wade SC; Flynn K; Fearon U; Veale DJ
Front Immunol; 2021; 12():672461. PubMed ID: 34248953
[TBL] [Abstract][Full Text] [Related]
19. Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Sato H; Muraoka S; Kusunoki N; Masuoka S; Yamada S; Ogasawara H; Imai T; Akasaka Y; Tochigi N; Takahashi H; Tsuchiya K; Kawai S; Nanki T
Arthritis Res Ther; 2017 Dec; 19(1):263. PubMed ID: 29191223
[TBL] [Abstract][Full Text] [Related]
20. Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway.
Guo X; Zhang D; Zhang X; Jiang J; Xue P; Wu C; Zhang J; Jin G; Huang Z; Yang J; Zhu X; Liu W; Xu G; Cui Z; Bao G
Tissue Cell; 2018 Dec; 55():63-70. PubMed ID: 30503061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
